As manager of Pew's drug safety project, Cosel works on federal initiatives to ensure the safety and oversight of the U.S. pharmaceutical supply chain. Prior to joining Pew, Cosel worked on issues of pharmaceutical safety and appropriate prescribing for national advocacy Organization Community Catalyst, and in grassroots development and capacity-building with the Fund for Public Interest Research in Cambridge, Massachusetts.
Cosel received her M.Sc. in human rights from the London School of Economics and a BA from Yale University.
Recent WorkView All
As repackagers, shippers, and businesses at every link in the supply chain work with regulators to implement the law, they have the opportunity to use serial numbers to provide even stronger protections against counterfeit, tainted, or stolen drugs. Read More
Traditional drug compounding—the creation of customized medicines to meet a patient's unique needs—has always been a part of pharmacy practice. But dramatic expansion of the sector in recent decades has resulted in production conditions on a scale closer to pharmaceutical manufacturing yet without the same oversight or quality standards. In fact, since 2001, over 25 pharmacy... Read More
Drug shortages are an ongoing U.S. public health crisis. New annually reported incidents grew dramatically from 117 in 2007 to a high of 255 in 2011. Although such reports have begun to decline, unresolved drug shortages persist. In 2012, the United States experienced 456 active drug shortages, many of them crucial medicines used in cancer treatment, surgery, and intensive care. Read More